Avidity Biosciences, Inc. — Director's Dealing 2020

Jun 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2020-06-16

Reporting Person: Alexandria Venture Investments, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-16	Common stock	C	502365	—	Acquired	502365	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-16	Series A convertible preferred stock	$	C	395000	Disposed		Common stock (187248.0)	Direct
2020-06-16	Series B convertible preferred stock	$	C	530616	Disposed		Common stock (251536.0)	Direct
2020-06-16	Series C convertible preferred stock	$	C	134126	Disposed		Common stock (63581.0)	Direct

Footnotes

F1: Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 2.1095 shares of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on June 16, 2020, for no additional consideration. The shares had no expiration date.

F2: Not applicable.